Press Coverage

Neurosurgeons identify malign tumors with Cellvizio optical biopsy

11 September 2015

A team of neurosurgeons in Germany has used the Cellvizio optical biopsy system to identify cancerous brain and spinal tumors in real time, suggesting that the technology could be used for immediate diagnosis in future operations to improve surgical outcomes and patient recovery.

Latest News

Mauna Kea Technologies Reports Strong Q1 2026 Core Sales Growth 

Mauna Kea Technologies Reports Strong Q1 2026 Core Sales Growth 

Mauna Kea Technologies Updates Its Financial Calendar 

Mauna Kea Technologies Updates Its Financial Calendar 

Mauna Kea Technologies Announces Major Milestone for Cellvizio® in Pancreatic Cysts with CLIMB Study Selected for ASGE Presidential Plenary Session at DDW 2026 

Mauna Kea Technologies Announces Major Milestone for Cellvizio® in Pancreatic Cysts with CLIMB Study Selected for ASGE Presidential Plenary Session at DDW 2026 

No results found.